学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

横川博英（ヨコカワヒロヒデ）

研究テーマ	臨床疫学
研究業績（論文）	１－１　欧文原著 1. Iwasaki N, Babazono T, Tomonaga O, Ogata M, Yokokawa H, Iwamoto Y. Mutations in the hepatocyte nuclear factor-1beta (MODY5) gene are not a major factor contributing to end-stage renal disease in Japanese people with diabetes mellitus. Diabetologia 44: 127-128, 2001, IF:6.206/CI:3 2. Iwasaki N, Babazono T, Tsuchiya K, Tomonaga O, Suzuki A, Togashi M, Ujihara N, Sakka Y, Yokokawa H, Ogata M, Nihei H, Iwamoto Y. Prevalence of A-to-G mutation at nucleotide 3243 of the mitochondrial tRNA(Leu(UUR)) gene in Japanese patients with diabetes mellitus and end stage renal disease. J Hum Genet 46: 330-334, 2001, IF:2.487/CI:20 3. Yokokawa H, Goto A, Watanabe K, Yasumura S. Evaluation of atherosclerosis-associated factors and pulse wave velocity for predicting cerebral infarction: a hospital-based, case-control study in Japan. Intern Med J 237: 161-167, 2007, IF:1.526/CI:7 4. Yokokawa H, Goto A, Terui K, Funami Y, Watanabe K, Yasumura S. Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan. J Clin Neurosci 15: 769-773, 2008, IF:1.387/CI:9 5. Yokokawa H, Goto A, Abe Y, Suzuki S, Yasumura S: Lifestyle characteristics and 3-year total mortality of Japanese with self-reported diabetes. Health Soc Care Community 16: 614-620, 2008, IF:1.557/CI:6 6. Yokokawa H, Goto A, Sanada H, Watanabe T, Yasumura S. Gaps between hypertension treatment guidelines and clinical practice in Japan; Baseline survey results from Fukushima Research of Hypertension (FRESH). J Clin Hypertens 11: 333-341, 2009, IF:2.549/CI:10 7. Yokokawa J, Saito H, Kanno Y, Honma F, Monoe K, Sakamoto N, Abe K, Takahashi A, Yokokawa H, Ohira H. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. J Gastroenterol Hepatol 25: 376-382, 2010, IF:3.322/CI:18 8. Yokokawa H, Goto A, Sanada H, Watanabe T, Yasumura S. Longitudinal community-based assessment of blood pressure control among Japanese hypertensive patients: Fukushima Research of Hypertension (FRESH). J Clin Hypertens 12: 166-173, 2010, IF:2.549/CI:7 9. Yokokawa H, Khue NT, Goto A, Nam TQ, Trung TT, Khoa VT, Ngoc NTB, Minh PN, Nguyen Quang Vinh NQ, Okayama A, Yasumura S. Diabetes Control among Vietnamese Patients in Ho Chi Minh City: An Observational Cross-Sectional Study. International Electronic Journal of Health Education, 13: 1-13, 2010, IF:0/CI:0 10. Goto A, Vinh NQ, Tu Van NT, Yokokawa H, Yasumura S, Khue NT. Epidemiology research training in Vietnam: Evaluation at the five year mark. Fukushima J Med Sci 56: 63-70, 2010, IF:0/CI:0 11. Saito T, Goto A, Yokokawa H, Sato Y, Yasumura S. Association between maternal feeling about pregnancy and child’s lifestyle. Fukushima J Med Sci 56: 80-88, 2010, IF:0/CI:1 12. Sato Y, Warabisako E, Yokokawa H, Harada S, Tsuda M, Horikawa R, MD, Kurokawa Y, Okada T, Ishizuka N, Kobayashi Y, Kishi M, Takahashi T, Kasahara Y, Imazeki N, Senoo A, Shuji Inoue. High cardiovascular risk factors among obese children in an urban area of Japan. Obes Res Clin Pract 4: e333-e337, 2010, IF:2.094/CI:1 13. Yokokawa H, Sanada H, Goto A, Watanabe T, Felder RA, Jose PA, Eisner GM, Yasumura S. Characteristics of antihypertensive medication and change of prescription over one year of follow-up in Japan; Fukushima Research of Hypertension (FRESH). Am J Hypertens 23: 1299-1305, 2010, IF:3.182/CI:3 14. Yokokawa H, Goto A, Khue NT, Nam TQ, Trung TT, Khoa VT, Ngoc NTB, Minh PN, Nguyen Quang Vinh NQ, Okayama A, Yasumura S. Characteristics of metabolic syndrome and its clinical components among diabetic Vietnamese patients: an observational cross-sectional study performed at two institutions in Ho Chi Minh City. Obes Res Clin Pract 4: e293-e299, 2010, IF: 2.094/CI:1 15. Yokokawa H, Kinoshita I, Hashiguchi T, Kako M, Sasaki K, Tamura K, Kintaka Y, Suzuki Y, Ishizuka N, Arai K, Kasahara Y, Kishi M, Kobayashi Y, Takahashi T, Shimizu H, Inoue S. Enhanced exercise-induced muscle damage and muscle protein degradation in streptozotocin-induced type 2 diabetic rats. J Diabetes Invest 2: 423-428, 2011, IF:2.294/CI:3 16. Yokokawa H, Yasumura S, Tanno K, Ohsawa M, Onoda T, Kazuyoshi Itai K, Sakata K, Kawamura K, Tanaka F, Yoshida Y, Nakamura M, Terayama Y, Ogawa A, Okayama A. Serum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a Japanese northern rural population. J Atheroscler Thromb 18: 89-98, 2011, IF:2.411/CI:21 17. Yokokawa J, Kanno Y, Saito H, Abe K, Takahashi A, Yokokawa H, Ohira H. Risk factors associated with relapse of type 1 autoimmune hepatitis in Japan. Hepatol Res 41: 641-646, 2011, IF:2.208/CI:9 18. Yokokawa H, Goto A, Sanada H, Watanabe T, Felder RA, Jose PA, Yasumura S. Achievement status toward goal blood pressure levels and healthy lifestyles among Japanese hypertensive patients; Cross sectional survey results from Fukushima Research of Hypertension (FRESH). Intern Med 50: 1149-1156, 2011, IF:0.832/CI:13 19. Fujibayashi K, Fukuda H, Yokokawa H, Haniu T, Oka F, Ooike M, Gunji T, Sasabe N, Okumura M, Iijima K, Hisaoka T, Isonuma H. The associations between healthy lifestyle behaviors and proteinuria and the estimated glomerular filtration rate (eGFR). J Atheroscler Thromb 19: 932-940, 2012, IF: 2.411/CI:11 20. Sanada H, Yokokawa H, Yoneda M, Yatabe J, Yatabe SM, Williams SM, Felder RA, Jose PA. High Body Mass Index is an Important Risk Factor of Developing Type 2 Diabetes. Intern Med 51: 1821-1826, 2012, IF: 0.832/CI:15 21. Aung MN, Yuasa M, Moolphate S, Nedsuwan S, Yokokawa H, Kitajima T, Minematsu K, Tanimura S, Fukuda H, Hiratsuka Y, Ono K, Kawai S, Marui E. Reducing salt intake for prevention of cardiovascular diseases in high-risk patients by advanced health education intervention (RESIP-CVD study), Northern Thailand: study protocol for a cluster randomized trial. Trials 13: 158, 2012, IF:1.859/CI:5 22. Matsuda N, Matsuda M, Notake S, Yokokawa H, Hiramatsu K, Kikuchi K. Evaluation of a simple protein-extraction method for species identification of clinically relevant staphylococci by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 50: 3862-3866, 2012, IF:3.631/CI:5 23. Saito T, Yokokawa H, Shimada K, Yasumura S. Self- perception of glycemic control among Japanese type 2 diabetic patients: Accuracy of patient perception and characteristics of patients with misperception. J Diabetes Invest 4: 206–213, 2013, IF: 2.294/CI:0 24. Aung MN, Yuasa M, Lorga T, Moolphate S, Fukuda H, Kitajima T, Yokokawa H, Minematsu K, Tanimura S, Hiratsuka Y, Ono K, Naunboonruang P, Thinuan P, Kawai S, Suya Y, Chumvicharana S, Marui E. Evidence-based new service package vs. routine service package for smoking cessation to prevent high risk patients from cardiovascular diseases (CVD): study protocol for randomized controlled trial. Trials 14: 419, 2013, IF: 1.859/CI:3 25. Shiga T, Yokokawa H, Taneda Y, Sugihara E, Meijyo M, Mitsuhashi K, Hisaoka T, Isonuma H. Age-specific effectiveness and safety of newly initiated insulin therapy in Japanese patients with uncontrolled diabetes. Diabetes Ther 4:473-486, 2013, IF: 2.419/CI:3 26. Oike M, Yokokawa H, Fukuda H, Haniu T, Oka F, Hisaoka T, Isonuma H. Association between abdominal fat distribution and a sign of atherosclerosis in the carotid artery. Obes Res Clin Pract 8: e448—e458, 2014, IF: 2.094/CI:3 27. Yokokawa H, Goto A, Sanada H, Watanabe T, Felder RA, Jose PA, Yasumura S. Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: Longitudinal data analysis from Fukushima Research of Hypertension (FRESH). Obes Res Clin Pract 8: e364-73. 2014, IF: 2.094/CI:2 28. Tanei M, Yokokawa H, Murai K, Sakamoto R, Amari Y, Boku S, Inui A, Fujibayashi K, Uehara Y, Isonuma H, Kikuchi K, Naito T. Factors influencing the diagnostic accuracy of the rapid influenza antigen detection test (RIADT): a cross-sectional study. BMJ Open 4: e003885, 2014, IF:2.562/CI:5 29. Yamanouchi M, Uehara Y, Yokokawa H, Hosoda T, Watanabe Y, Shiga T, Inui A, Otsuki Y, Fujibayashi K, Isonuma H, Naito T. Analysis of 256 cases of classic fever of unknown origin. Intern Med 53: 2471-2475, 2014, IF:0.832/CI:4 30. Amari Y, Uehara Y, Watanabe Y, Inui A, Sugihara E, Yokokawa H, Isonuma H, Naito T: Status of Antimicrobial use among dentists in Japan. J Gen Hosp Med 6: 8-15, 2014, IF:0/CI:0 31. Suzuki-Saito T, Yokokawa H, Shimada K, Goto A, Yasumura S. Factors associated with change in glycemic control in Japanese patients: Analyses of patients’ misperception. J Diabetol 3: 1, 2014, IF:0/CI:0 32. Okamoto A, Yokokawa H, Sanada H. Dipeptidyl Peptidase-4 Inhibitor (Vildagliptin) Improves Glycemic Control After Meal Tolerance Test by Suppressing Glucagon Release. Drugs R D 14:227-232, 2014, IF:1.707/CI:0 33. Takanashi Y, Mashiko H, Yokokawa H, Kawasaki Y, Itagaki1S, Ishikawa H, Miyashita N, Hayashi Y, Kudo A, Oga K, Matsuura R, Niwa S. Attention-Deficit/Hyperactivity Disorder in Adults with High-Functioning Pervasive Developmental Disorders in Japan. Open Journal of Psychiatry 4: 372-380, 2014, IF:0/CI:0 34. Sanada H, Yokokawa H, Yatabe J, Williams SM, Felder RA, Jose PA, Takenosita S. Association between lifestyle-related disorders and visceral fat mass in Japanese males: a hospital based cross-sectional study. Environ Health Prev Med 19: 429-435, 2014, IF:0/CI:0 35. Goto Y, Yokokawa H, Fukuda H, Naito T, Hisaoka T, Isonuma H. Body mass index and waist circumference are independent risk factors for low vital capacity among Japanese participants of a health checkup: a single-institution cross-sectional study. Environ Health Prev Med 20: 108-15, 2015, IF:0/CI:0 36. Yokokawa J, Kanno Y, Abe K, Saito H, Monoe K, Katsushima F, Sakamoto N, Takahashi A, Yokokawa H, Ohira H. Anti-nucleosome autoantibodies as markers for autoimmune hepatitis and their correlation with disease activity. Hepatol Res 44: 420-428, 2014, IF:2.08/CI:3 37. Fujibayashi K, Yokokawa H, Gunji T, Sasabe N, Okumura M, Iijima K, Haniu T, Hisaoka T, Fukuda H. Utility of 75 g oral glucose tolerance test results and hemoglobin A1c values for predicting the incidence of diabetes mellitus among middle-aged Japanese men~A large-scale retrospective cohort study performed at a single hospital~. Intern Med 54: 717-23, 2015, IF:0.832/CI:3 38. Yokokawa H, Yuasa M, Sanada H, Hisaoka T, Fukuda H. Age- and sex-specific impact of health literacy on healthy lifestyle characteristics among Japanese residents in a rural community. Health. 7: 679-688, 2015, IF:0/CI:0 39. Kudo N, Yokokawa H, Fukuda H, Sanada H, Miwa Y, Hisaoka1 T, Isonuma H. Achievement of target blood pressure levels among Japanese workers with hypertension and healthy lifestyle characteristics associated with therapeutic failure. PLoS One 10: e0133641, 2015, IF:3.057/CI:1 40. Yokokawa H, Fukuda H, Suzuki A, Fujibayashi K, Naito T, Uehara Y, Nakayama A, Matsuo H, Sanada H, Jose PA, Miwa Y, Hisaoka T, Isonuma H. An association between serum uric acid levels/hyperuricemia and hypertension among 85,900 Japanese workers; Risk of hypertension. J Clin Hypertens 18: 53-59, 2015, IF: 2.549/CI:2 41. Yokokawa H, Yuasa M, Nedsuwan S, Moolphate S, Fukuda H, Kitajima T, Minematsu K, Tanimura S, Marui E. Daily salt intake estimated by overnight urine collections and basic characteristics of participants with a high cardiovascular disease risk in Thailand. Asia Pac J Clin Nutr. 25: 39-45, 2016, IF:1.350/CI:1 42. Yokokawa H, Fukuda H, Yuasa M, Sanada H, Hisaoka T, Naito T. Association between health literacy and metabolic syndrome or healthy lifestyle characteristics among community-dwelling Japanese people. Diabetol Metab syndr. 8: 30, 2016, IF:2.119/CI:1 43. Fujibayashi K, Gunji T, Yokokawa H, Naito T, Sasabe N, Okumura M, Iijima K, Shibuya K, Hisaoka T, Fukuda H. The Relationships between Metabolic Disorders (Hypertension, Dyslipidemia, and Impaired Glucose Tolerance) and Computed Tomography-Based Indices of Hepatic Steatosis or Visceral Fat Accumulation in Middle-Aged Japanese Men. PLoS One 11: e0149689, 2016, IF: 3.057/CI:1 44. Okamoto A, Yokokawa H, Sanada H, Naito T. Changes in levels of biomarkers associated with adipocyte function and insulin and glucagon kinetics during treatment with dapagliflozin among obese type 2 diabetes mellitus (T2DM) patients. Drugs RD 16: 255-261, 2016, IF: 1.707/CI:0 45. Kudo N, Yokokawa H, Fukuda H, Hisaoka T, Isonuma H, Naito T. Associations between health literacy and healthy lifestyle characteristics among Japanese outpatients with lifestyle-related disorders. J Gen Famil Med 17: 299-306, 2016, IF:0/CI:0 46. Fujibayashi K, Hayashi M, Yokokawa H, Naito T. Changes in antidiabetic prescription patterns and indicators of diabetic control among 200,000 patients over 13 years at a single institution in Japan. Diabetol Metab Syndr 8:72, 2016, IF:2.119/CI:0 47. Kobayashi T, Yokokawa H, Fujibayashi K, Haniu T, Hisaoka T, Fukuda H, Naito T. Association between high cystatin C levels and carotid atherosclerosis. World J Cardiol 26: 174-181, 2017, IF:0/CI:0 48. Miyagami T, Yokokawa H, Fujibayashi K, Gunji T, Sasabe N, Okumura M, Iijima K, Naito T. The waist circumference-adjusted associations between hyperuricemia and other lifestyle-related diseases. Diabetol Metab Syndr 10:11, 2017, IF: 2.119/CI:0 49. Takahashi Y, Yokokawa H, Fujibayashi K, Fukuda H, Watada H, Daida H, Naito T: Frequency of examinations for cancer among patients with lifestyle-related diseases. J Hosp Gen Med 13:1-9, 2017, IF:0/CI:0 50. Morita F, Yokokawa H, Matsuda N, Fujibayashi K, Uehara Y, Kobayashi H, Naito T: Comparative efficacy of Goreisan and probiotics in Japanese adults with acute infectious gastroenteritis: A randomized controlled trial. Traditional & Kampo Medicine 31: S166-S167, 2017 IF:0/CI:0 51. Nakamura N, Uehara Y, Fukui S, Fujibayashi K, Yokokawa H, Naito T. Useful Predictive Factors for Bacteremia among Outpatients with Pyelonephritis. Intern Med. 2018 Jan 11. [Epub ahead of print] 52. Naito T, Yokokawa H, Watanabe A. Impact of the national routine vaccination program on 23-valent pneumococcal polysaccharide vaccine vaccination rates in elderly persons in Japan. J Infect Chemother. 2018 Feb 1. [Epub ahead of print] 53. Fujibayashi K, Takahashi H, Tanei M, Uehara Y, Yokokawa H, Naito T. A New Influenza-Tracking Smartphone App (Flu-Report) Based on a Self-Administered Questionnaire: Cross-Sectional Study. JMIR Mhealth Uhealth. 2018 Jun 6;6(6):e136. 54. Fukushima S, Suzuki M, Abe N, Shimada Y, Ohno M, Yokokawa H, Hori S, Naito T. Impact of the introduction of a vaccination status checkbox in electronic medical records on pneumococcal vaccination rates. Juntendo Med J, 65: 92-94, 2018. 55. Katayama A, Yokokawa H, Fukuda H, Yoshiki Ono Y, Hiroshi Isonuma H, Hisaoka T, Naito T. Achievement of target serum uric acid levels and factors associated with therapeutic failure among Japanese male patients treated for hyperuricemia/gout. Intern Med. 2019 Jan 10. [Epub ahead of print] 56. Aung MN, Yuasa M, Moolphate S, Lorga T, Yokokawa H, Fukuda H, Kitajima T, Tanimura S, Hiratsuka Y, Ono K, Thinuan P, Minematsu K, Deerojanawong J, Suya Y, Marui E. Effectiveness of a new multi-component smoking cessation service package for patients with hypertension and diabetes in northern Thailand: a randomized controlled trial (ESCAPE study). Subst Abuse Treat Prev Policy. 22:4:10. 2019 57. Yokokawa H, Fukuda H, Fujibayashi K, Yuasa M, Okamoto A, Taneda Y, Tani M, Sugimoto K, Hisaoka T, Naito T. Examining health literacy and healthy lifestyle characteristics as associated with glycemic control among community-dwelling Japanese people. Diabetes Manag. 9:39-47.2019 58. Sakama R, Yokokawa H, Fujibayashi K, Naito T, Sato Y, Yamanaka C, Kikuya M, Miyashita M, Kuriyama S. Psychological Characteristics of Children at Two Years after the Great East Japan Earthquake: Analyses of Telephone Consultation Records. Tohoku J Exp Med. 249:85-92. 2019 59. Kaito S, Taniguchi Y, Kitamura A, Seino S, Amano H, Yokoyama Y, Fukuda H, Yokokawa H, Fujiwara Y, Shinkai S, Naito T. Trajectories of Kidney Function and Associated Factors Among Community-Dwelling Older Adults in Japan: The Kusatsu Study. Clin Exp Nephrol. Dec 26. 2019 [Epub ahead of print] 60. Naito T, Suzuki M, Fujibayashi K, Kanazawa A, Takahashi H, Yokokawa H, Watanabe A. The estimated impact of the 5-year national vaccination program on the trend of 23-valent pneumococcal polysaccharide vaccine vaccination rates in the elderly in Japan, 2009-2018. J Infect Chemother. Jan 7. 2020. [Epub ahead of print] 61. Miyagami T, Yokokawa H, Fujibayashi K, Fukuda H, Hisaoka T, Naito T. Assessing lifestyle-related diseases with body and muscle mass using bioelectrical impedance analysis. Osteoporos Sarcopenia. 2020;6:27-32. 62. Matsushita S, Kishida A, Wakamatsu Y, Mukaida H, Yokokawa H, Yamamoto T, Amano A. Factors influencing activated clotting time following heparin administration for the initiation of cardiopulmonary bypass. Gen Thorac Cardiovasc Surg. 2020 Jul 12. 63. Yokokawa H, Fukuda H, Saita M, Miyagami T, Takahashi Y, Hisaoka T, Naito T. Serum zinc concentrations and characteristics of zinc deficiency/ marginal deficiency among Japanese subjects. J Gen Fam Med. 2020;21:248–255. 64. Naito T, Suzuki M, Kanazawa A, Takahashi H, Fujibayashi K, Yokokawa H, Kuwatsuru R, Watanabe A. Pneumococcal vaccination reduces in-hospital mortality, length of stay and medical expenditure in hospitalized elderly patients. J Infect Chemother. 2020;26:715-721. 65. Yokokawa H, Yuasa M, Nedsuwan S, Moolphate S, Fukuda H, Kitajima T, Kazuo Minematsu K, Tanimura S, Marui E. An impact of dietary intervention on blood pressures among diabetic and/or hypertensive patients with high risk of cardiovascular disorders in Northern Thailand by Cluster randomized trial. J Gen Fam Med. 2021;22: 28-37. 66. Naito T, Endo K, Fukushima S, Suzuki M, Fukui Y, Saita M, Yokokawa H. A preliminary analysis of the performance of a targeted HIV electronic medical records alert system: A single hospital experience. J Infect Chemother. 2021;27:123-125. 67. Goto K, Yokokawa H, Fukuda H, Saita M, Hamada C, Hisaoka T, Naito T. An association between subcutaneous fat mass accumulation and Hypertension. J Gen Fam Med. 2021;00:1-9. 68. Yokokawa H, Fukuda H, Saita M, Goto K, Kaku T, Miyagami T, Takahashi Y, Hamada C, Hisaoka T, Naito T. An association between visceral or subcutaneous fat accumulation and diabetes mellitus among Japanese subjects. Diabetol Metab Syndr. 2021;13:44. 69. Hayashi Y, Yokokawa H, Fukuda H, Saita M, Miyagami T, Takahashi Y, Hisaoka T, Naito T. Association between visceral or subcutaneous fat accumulation and B-type natriuretic peptide among Japanese subjects: a cross-sectional study. J Clin Med. 2021;10:1315. 70. Hamaya R, Fukuda H, Takebayashi M, Mori M, Matsushima R, Nakano K, Miyake K, Tani Y, Yokokawa H. The effects of kencom, an mHealth app with integrated functions for healthy lifestyles. J Med Internet Res. 2021;23: 1-13. 71. Okamoto A, Yokokawa H, Nagamine T, Fukuda H, Hisaoka T, Naito T. Efficacy and safety of semaglutide in glycemic control, body weight management, lipid profiles and other biomarkers among obese type 2 diabetes patients initiated or switched to semaglutide from other GLP-1 receptor agonists. J Diabetes Metab Disord. 2021; Published online 25. 10.1007/s40200-021-00899-9. 72. Fujisawa T, Fukuda H, Sakamoto N, Hojo M, Tomishima K, Ishii S, Yokokawa H, Saita M, Naito T, Nagahara A, Watanabe S, Isayama H. Relief Effect of Carbon Dioxide Insufflation in Transnasal Endoscopy for Health Checks-A Prospective, Double-Blind, Case-Control Trial. J Clin Med. 2022;11:1231. doi: 10.3390/jcm11051231. 73. Sachkouskaya A, Sharshakova T, Kovalevsky D, Rusalenko M, Savasteeva I, Goto A, Yokokawa H, Kumagai A, Takahashi J. Barriers to Prevention and Treatment of Type 2 Diabetes Mellitus Among Outpatients in Belarus. Front Clin Diabetes Healthc. 06 January 2022. ２．和文原著 1. 羽二生知美, 福田洋, 横川博英, 藤林和俊, 久岡英彦, 礒沼弘；高尿酸血症を含めた慢性腎臓病Chronic Kidney Disease（CKD）の危険因子の横断的検討．日本臨床生理学会雑誌 42, 249-255, 2012. 2. 横川博英，安村誠司，丹野高三，大澤正樹，小野田敏行，板井一好，川村和子，坂田清美．閉じこもりと要介護発生との関連についての検討；岩手県北地域コホート研究より．日本老年医学会雑誌 46, 447-457, 2009. 3. 鈴木直子，後藤あや, 横川博英, 安村誠司．地域在住高齢者のIADLの「実行状況」と「能力」の１年後の変化．日本老年医学会雑誌 46, 47-54, 2009. 4. 鈴木直子, 牧上久仁子, 後藤あや, 横川博英, 安村誠司．地域在住高齢者のIADLの「実行状況」と「能力」による評価の検討　基本チェックリストと老研式活動能力指標から．日本老年医学会雑誌，44，619-626，2007． 5. 舟見敬成，照井和史，横川博英．教育入院の長期効果と患者教育への一提案－行動変化ステージ別介入方法について－．東北理学療法学，18，13-17，2006．

研究テーマ

臨床疫学

研究業績（論文）

１－１　欧文原著
1. Iwasaki N, Babazono T, Tomonaga O, Ogata M, Yokokawa H, Iwamoto Y. Mutations in the hepatocyte nuclear factor-1beta (MODY5) gene are not a major factor contributing to end-stage renal disease in Japanese people with diabetes mellitus. Diabetologia 44: 127-128, 2001, IF:6.206/CI:3
2. Iwasaki N, Babazono T, Tsuchiya K, Tomonaga O, Suzuki A, Togashi M, Ujihara N, Sakka Y, Yokokawa H, Ogata M, Nihei H, Iwamoto Y. Prevalence of A-to-G mutation at nucleotide 3243 of the mitochondrial tRNA(Leu(UUR)) gene in Japanese patients with diabetes mellitus and end stage renal disease. J Hum Genet 46: 330-334, 2001, IF:2.487/CI:20
3. Yokokawa H, Goto A, Watanabe K, Yasumura S. Evaluation of atherosclerosis-associated factors and pulse wave velocity for predicting cerebral infarction: a hospital-based, case-control study in Japan. Intern Med J 237: 161-167, 2007, IF:1.526/CI:7
4. Yokokawa H, Goto A, Terui K, Funami Y, Watanabe K, Yasumura S. Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan. J Clin Neurosci 15: 769-773, 2008, IF:1.387/CI:9
5. Yokokawa H, Goto A, Abe Y, Suzuki S, Yasumura S: Lifestyle characteristics and 3-year total mortality of Japanese with self-reported diabetes. Health Soc Care Community 16: 614-620, 2008, IF:1.557/CI:6
6. Yokokawa H, Goto A, Sanada H, Watanabe T, Yasumura S. Gaps between hypertension treatment guidelines and clinical practice in Japan; Baseline survey results from Fukushima Research of Hypertension (FRESH). J Clin Hypertens 11: 333-341, 2009, IF:2.549/CI:10
7. Yokokawa J, Saito H, Kanno Y, Honma F, Monoe K, Sakamoto N, Abe K, Takahashi A, Yokokawa H, Ohira H. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. J Gastroenterol Hepatol 25: 376-382, 2010, IF:3.322/CI:18
8. Yokokawa H, Goto A, Sanada H, Watanabe T, Yasumura S. Longitudinal community-based assessment of blood pressure control among Japanese hypertensive patients: Fukushima Research of Hypertension (FRESH). J Clin Hypertens 12: 166-173, 2010, IF:2.549/CI:7
9. Yokokawa H, Khue NT, Goto A, Nam TQ, Trung TT, Khoa VT, Ngoc NTB, Minh PN, Nguyen Quang Vinh NQ, Okayama A, Yasumura S. Diabetes Control among Vietnamese Patients in Ho Chi Minh City: An Observational Cross-Sectional Study. International Electronic Journal of Health Education, 13: 1-13, 2010, IF:0/CI:0
10. Goto A, Vinh NQ, Tu Van NT, Yokokawa H, Yasumura S, Khue NT. Epidemiology research training in Vietnam: Evaluation at the five year mark. Fukushima J Med Sci 56: 63-70, 2010, IF:0/CI:0
11. Saito T, Goto A, Yokokawa H, Sato Y, Yasumura S. Association between maternal feeling about pregnancy and child’s lifestyle. Fukushima J Med Sci 56: 80-88, 2010, IF:0/CI:1
12. Sato Y, Warabisako E, Yokokawa H, Harada S, Tsuda M, Horikawa R, MD, Kurokawa Y, Okada T, Ishizuka N, Kobayashi Y, Kishi M, Takahashi T, Kasahara Y, Imazeki N, Senoo A, Shuji Inoue. High cardiovascular risk factors among obese children in an urban area of Japan. Obes Res Clin Pract 4: e333-e337, 2010, IF:2.094/CI:1
13. Yokokawa H, Sanada H, Goto A, Watanabe T, Felder RA, Jose PA, Eisner GM, Yasumura S. Characteristics of antihypertensive medication and change of prescription over one year of follow-up in Japan; Fukushima Research of Hypertension (FRESH). Am J Hypertens 23: 1299-1305, 2010, IF:3.182/CI:3
14. Yokokawa H, Goto A, Khue NT, Nam TQ, Trung TT, Khoa VT, Ngoc NTB, Minh PN, Nguyen Quang Vinh NQ, Okayama A, Yasumura S. Characteristics of metabolic syndrome and its clinical components among diabetic Vietnamese patients: an observational cross-sectional study performed at two institutions in Ho Chi Minh City. Obes Res Clin Pract 4: e293-e299, 2010, IF: 2.094/CI:1
15. Yokokawa H, Kinoshita I, Hashiguchi T, Kako M, Sasaki K, Tamura K, Kintaka Y, Suzuki Y, Ishizuka N, Arai K, Kasahara Y, Kishi M, Kobayashi Y, Takahashi T, Shimizu H, Inoue S. Enhanced exercise-induced muscle damage and muscle protein degradation in streptozotocin-induced type 2 diabetic rats. J Diabetes Invest 2: 423-428, 2011, IF:2.294/CI:3
16. Yokokawa H, Yasumura S, Tanno K, Ohsawa M, Onoda T, Kazuyoshi Itai K, Sakata K, Kawamura K, Tanaka F, Yoshida Y, Nakamura M, Terayama Y, Ogawa A, Okayama A. Serum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a Japanese northern rural population. J Atheroscler Thromb 18: 89-98, 2011, IF:2.411/CI:21
17. Yokokawa J, Kanno Y, Saito H, Abe K, Takahashi A, Yokokawa H, Ohira H. Risk factors associated with relapse of type 1 autoimmune hepatitis in Japan. Hepatol Res 41: 641-646, 2011, IF:2.208/CI:9
18. Yokokawa H, Goto A, Sanada H, Watanabe T, Felder RA, Jose PA, Yasumura S. Achievement status toward goal blood pressure levels and healthy lifestyles among Japanese hypertensive patients; Cross sectional survey results from Fukushima Research of Hypertension (FRESH). Intern Med 50: 1149-1156, 2011, IF:0.832/CI:13
19. Fujibayashi K, Fukuda H, Yokokawa H, Haniu T, Oka F, Ooike M, Gunji T, Sasabe N, Okumura M, Iijima K, Hisaoka T, Isonuma H. The associations between healthy lifestyle behaviors and proteinuria and the estimated glomerular filtration rate (eGFR). J Atheroscler Thromb 19: 932-940, 2012, IF: 2.411/CI:11
20. Sanada H, Yokokawa H*, Yoneda M, Yatabe J, Yatabe SM, Williams SM, Felder RA, Jose PA. High Body Mass Index is an Important Risk Factor of Developing Type 2 Diabetes. Intern Med 51: 1821-1826, 2012, IF: 0.832/CI:15
21. Aung MN, Yuasa M, Moolphate S, Nedsuwan S, Yokokawa H, Kitajima T, Minematsu K, Tanimura S, Fukuda H, Hiratsuka Y, Ono K, Kawai S, Marui E. Reducing salt intake for prevention of cardiovascular diseases in high-risk patients by advanced health education intervention (RESIP-CVD study), Northern Thailand: study protocol for a cluster randomized trial. Trials 13: 158, 2012, IF:1.859/CI:5
22. Matsuda N, Matsuda M, Notake S, Yokokawa H, Hiramatsu K, Kikuchi K. Evaluation of a simple protein-extraction method for species identification of clinically relevant staphylococci by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 50: 3862-3866, 2012, IF:3.631/CI:5
23. Saito T, Yokokawa H, Shimada K, Yasumura S. Self- perception of glycemic control among Japanese type 2 diabetic patients: Accuracy of patient perception and characteristics of patients with misperception. J Diabetes Invest 4: 206–213, 2013, IF: 2.294/CI:0
24. Aung MN, Yuasa M, Lorga T, Moolphate S, Fukuda H, Kitajima T, Yokokawa H, Minematsu K, Tanimura S, Hiratsuka Y, Ono K, Naunboonruang P, Thinuan P, Kawai S, Suya Y, Chumvicharana S, Marui E. Evidence-based new service package vs. routine service package for smoking cessation to prevent high risk patients from cardiovascular diseases (CVD): study protocol for randomized controlled trial. Trials 14: 419, 2013, IF: 1.859/CI:3
25. Shiga T, Yokokawa H*, Taneda Y, Sugihara E, Meijyo M, Mitsuhashi K, Hisaoka T, Isonuma H. Age-specific effectiveness and safety of newly initiated insulin therapy in Japanese patients with uncontrolled diabetes. Diabetes Ther 4:473-486, 2013, IF: 2.419/CI:3
26. Oike M, Yokokawa H*, Fukuda H, Haniu T, Oka F, Hisaoka T, Isonuma H. Association between abdominal fat distribution and a sign of atherosclerosis in the carotid artery. Obes Res Clin Pract 8: e448—e458, 2014, IF: 2.094/CI:3
27. Yokokawa H, Goto A, Sanada H, Watanabe T, Felder RA, Jose PA, Yasumura S. Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: Longitudinal data analysis from Fukushima Research of Hypertension (FRESH). Obes Res Clin Pract 8: e364-73. 2014, IF: 2.094/CI:2
28. Tanei M, Yokokawa H, Murai K, Sakamoto R, Amari Y, Boku S, Inui A, Fujibayashi K, Uehara Y, Isonuma H, Kikuchi K, Naito T. Factors influencing the diagnostic accuracy of the rapid influenza antigen detection test (RIADT): a cross-sectional study. BMJ Open 4: e003885, 2014, IF:2.562/CI:5
29. Yamanouchi M, Uehara Y, Yokokawa H, Hosoda T, Watanabe Y, Shiga T, Inui A, Otsuki Y, Fujibayashi K, Isonuma H, Naito T. Analysis of 256 cases of classic fever of unknown origin. Intern Med 53: 2471-2475, 2014, IF:0.832/CI:4
30. Amari Y, Uehara Y, Watanabe Y, Inui A, Sugihara E, Yokokawa H, Isonuma H, Naito T: Status of Antimicrobial use among dentists in Japan. J Gen Hosp Med 6: 8-15, 2014, IF:0/CI:0
31. Suzuki-Saito T, Yokokawa H, Shimada K, Goto A, Yasumura S. Factors associated with change in glycemic control in Japanese patients: Analyses of patients’ misperception. J Diabetol 3: 1, 2014, IF:0/CI:0
32. Okamoto A, Yokokawa H*, Sanada H. Dipeptidyl Peptidase-4 Inhibitor (Vildagliptin) Improves Glycemic Control After Meal Tolerance Test by Suppressing Glucagon Release. Drugs R D 14:227-232, 2014, IF:1.707/CI:0
33. Takanashi Y, Mashiko H, Yokokawa H, Kawasaki Y, Itagaki1S, Ishikawa H, Miyashita N, Hayashi Y, Kudo A, Oga K, Matsuura R, Niwa S. Attention-Deficit/Hyperactivity Disorder in Adults with High-Functioning Pervasive Developmental Disorders in Japan. Open Journal of Psychiatry 4: 372-380, 2014, IF:0/CI:0
34. Sanada H, Yokokawa H*, Yatabe J, Williams SM, Felder RA, Jose PA, Takenosita S. Association between lifestyle-related disorders and visceral fat mass in Japanese males: a hospital based cross-sectional study. Environ Health Prev Med 19: 429-435, 2014, IF:0/CI:0
35. Goto Y, Yokokawa H*, Fukuda H, Naito T, Hisaoka T, Isonuma H. Body mass index and waist circumference are independent risk factors for low vital capacity among Japanese participants of a health checkup: a single-institution cross-sectional study. Environ Health Prev Med 20: 108-15, 2015, IF:0/CI:0
36. Yokokawa J, Kanno Y, Abe K, Saito H, Monoe K, Katsushima F, Sakamoto N, Takahashi A, Yokokawa H, Ohira H. Anti-nucleosome autoantibodies as markers for autoimmune hepatitis and their correlation with disease activity. Hepatol Res 44: 420-428, 2014, IF:2.08/CI:3
37. Fujibayashi K, Yokokawa H, Gunji T, Sasabe N, Okumura M, Iijima K, Haniu T, Hisaoka T, Fukuda H. Utility of 75 g oral glucose tolerance test results and hemoglobin A1c values for predicting the incidence of diabetes mellitus among middle-aged Japanese men~A large-scale retrospective cohort study performed at a single hospital~. Intern Med 54: 717-23, 2015, IF:0.832/CI:3
38. Yokokawa H, Yuasa M, Sanada H, Hisaoka T, Fukuda H. Age- and sex-specific impact of health literacy on healthy lifestyle characteristics among Japanese residents in a rural community. Health. 7: 679-688, 2015, IF:0/CI:0
39. Kudo N, Yokokawa H*, Fukuda H, Sanada H, Miwa Y, Hisaoka1 T, Isonuma H. Achievement of target blood pressure levels among Japanese workers with hypertension and healthy lifestyle characteristics associated with therapeutic failure. PLoS One 10: e0133641, 2015, IF:3.057/CI:1
40. Yokokawa H, Fukuda H, Suzuki A, Fujibayashi K, Naito T, Uehara Y, Nakayama A, Matsuo H, Sanada H, Jose PA, Miwa Y, Hisaoka T, Isonuma H. An association between serum uric acid levels/hyperuricemia and hypertension among 85,900 Japanese workers; Risk of hypertension. J Clin Hypertens 18: 53-59, 2015, IF: 2.549/CI:2
41. Yokokawa H, Yuasa M, Nedsuwan S, Moolphate S, Fukuda H, Kitajima T, Minematsu K, Tanimura S, Marui E. Daily salt intake estimated by overnight urine collections and basic characteristics of participants with a high cardiovascular disease risk in Thailand. Asia Pac J Clin Nutr. 25: 39-45, 2016, IF:1.350/CI:1
42. Yokokawa H, Fukuda H, Yuasa M, Sanada H, Hisaoka T, Naito T. Association between health literacy and metabolic syndrome or healthy lifestyle characteristics among community-dwelling Japanese people. Diabetol Metab syndr. 8: 30, 2016, IF:2.119/CI:1
43. Fujibayashi K, Gunji T, Yokokawa H, Naito T, Sasabe N, Okumura M, Iijima K, Shibuya K, Hisaoka T, Fukuda H. The Relationships between Metabolic Disorders (Hypertension, Dyslipidemia, and Impaired Glucose Tolerance) and Computed Tomography-Based Indices of Hepatic Steatosis or Visceral Fat Accumulation in Middle-Aged Japanese Men. PLoS One 11: e0149689, 2016, IF: 3.057/CI:1
44. Okamoto A, Yokokawa H*, Sanada H, Naito T. Changes in levels of biomarkers associated with adipocyte function and insulin and glucagon kinetics during treatment with dapagliflozin among obese type 2 diabetes mellitus (T2DM) patients. Drugs RD 16: 255-261, 2016, IF: 1.707/CI:0
45. Kudo N, Yokokawa H*, Fukuda H, Hisaoka T, Isonuma H, Naito T. Associations between health literacy and healthy lifestyle characteristics among Japanese outpatients with lifestyle-related disorders. J Gen Famil Med 17: 299-306, 2016, IF:0/CI:0
46. Fujibayashi K, Hayashi M, Yokokawa H, Naito T. Changes in antidiabetic prescription patterns and indicators of diabetic control among 200,000 patients over 13 years at a single institution in Japan. Diabetol Metab Syndr 8:72, 2016, IF:2.119/CI:0
47. Kobayashi T, Yokokawa H*, Fujibayashi K, Haniu T, Hisaoka T, Fukuda H, Naito T. Association between high cystatin C levels and carotid atherosclerosis. World J Cardiol 26: 174-181, 2017, IF:0/CI:0
48. Miyagami T, Yokokawa H*, Fujibayashi K, Gunji T, Sasabe N, Okumura M, Iijima K, Naito T. The waist circumference-adjusted associations between hyperuricemia and other lifestyle-related diseases. Diabetol Metab Syndr 10:11, 2017, IF: 2.119/CI:0
49. Takahashi Y, Yokokawa H*, Fujibayashi K, Fukuda H, Watada H, Daida H, Naito T: Frequency of examinations for cancer among patients with lifestyle-related diseases. J Hosp Gen Med 13:1-9, 2017, IF:0/CI:0
50. Morita F, Yokokawa H*, Matsuda N, Fujibayashi K, Uehara Y, Kobayashi H, Naito T: Comparative efficacy of Goreisan and probiotics in Japanese adults with acute infectious gastroenteritis: A randomized controlled trial. Traditional & Kampo Medicine 31: S166-S167, 2017 IF:0/CI:0
51. Nakamura N, Uehara Y, Fukui S, Fujibayashi K, Yokokawa H, Naito T. Useful Predictive Factors for Bacteremia among Outpatients with Pyelonephritis. Intern Med. 2018 Jan 11. [Epub ahead of print]
52. Naito T, Yokokawa H, Watanabe A. Impact of the national routine vaccination program on 23-valent pneumococcal polysaccharide vaccine vaccination rates in elderly persons in Japan. J Infect Chemother. 2018 Feb 1. [Epub ahead of print]
53. Fujibayashi K, Takahashi H, Tanei M, Uehara Y, Yokokawa H, Naito T. A New Influenza-Tracking Smartphone App (Flu-Report) Based on a Self-Administered Questionnaire: Cross-Sectional Study. JMIR Mhealth Uhealth. 2018 Jun 6;6(6):e136.
54. Fukushima S, Suzuki M, Abe N, Shimada Y, Ohno M, Yokokawa H, Hori S, Naito T. Impact of the introduction of a vaccination status checkbox in electronic medical records on pneumococcal vaccination rates. Juntendo Med J, 65: 92-94, 2018.
55. Katayama A, Yokokawa H*, Fukuda H, Yoshiki Ono Y, Hiroshi Isonuma H, Hisaoka T, Naito T. Achievement of target serum uric acid levels and factors associated with therapeutic failure among Japanese male patients treated for hyperuricemia/gout. Intern Med. 2019 Jan 10. [Epub ahead of print]
56. Aung MN, Yuasa M, Moolphate S, Lorga T, Yokokawa H, Fukuda H, Kitajima T, Tanimura S, Hiratsuka Y, Ono K, Thinuan P, Minematsu K, Deerojanawong J, Suya Y, Marui E. Effectiveness of a new multi-component smoking cessation service package for patients with hypertension and diabetes in northern Thailand: a randomized controlled trial (ESCAPE study). Subst Abuse Treat Prev Policy. 22:4:10. 2019
57. Yokokawa H, Fukuda H, Fujibayashi K, Yuasa M, Okamoto A, Taneda Y, Tani M, Sugimoto K, Hisaoka T, Naito T. Examining health literacy and healthy lifestyle characteristics as associated with glycemic control among community-dwelling Japanese people. Diabetes Manag. 9:39-47.2019
58. Sakama R, Yokokawa H*, Fujibayashi K, Naito T, Sato Y, Yamanaka C, Kikuya M, Miyashita M, Kuriyama S. Psychological Characteristics of Children at Two Years after the Great East Japan Earthquake: Analyses of Telephone Consultation Records. Tohoku J Exp Med. 249:85-92. 2019
59. Kaito S, Taniguchi Y, Kitamura A, Seino S, Amano H, Yokoyama Y, Fukuda H, Yokokawa H, Fujiwara Y, Shinkai S, Naito T. Trajectories of Kidney Function and Associated Factors Among Community-Dwelling Older Adults in Japan: The Kusatsu Study. Clin Exp Nephrol. Dec 26. 2019 [Epub ahead of print]
60. Naito T, Suzuki M, Fujibayashi K, Kanazawa A, Takahashi H, Yokokawa H, Watanabe A. The estimated impact of the 5-year national vaccination program on the trend of 23-valent pneumococcal polysaccharide vaccine vaccination rates in the elderly in Japan, 2009-2018. J Infect Chemother. Jan 7. 2020. [Epub ahead of print]
61. Miyagami T, Yokokawa H*, Fujibayashi K, Fukuda H, Hisaoka T, Naito T. Assessing lifestyle-related diseases with body and muscle mass using bioelectrical impedance analysis. Osteoporos Sarcopenia. 2020;6:27-32.
62. Matsushita S, Kishida A, Wakamatsu Y, Mukaida H, Yokokawa H, Yamamoto T, Amano A. Factors influencing activated clotting time following heparin administration for the initiation of cardiopulmonary bypass. Gen Thorac Cardiovasc Surg. 2020 Jul 12.
63. Yokokawa H, Fukuda H, Saita M, Miyagami T, Takahashi Y, Hisaoka T, Naito T. Serum zinc concentrations and characteristics of zinc deficiency/ marginal deficiency among Japanese subjects. J Gen Fam Med. 2020;21:248–255.
64. Naito T, Suzuki M, Kanazawa A, Takahashi H, Fujibayashi K, Yokokawa H, Kuwatsuru R, Watanabe A. Pneumococcal vaccination reduces in-hospital mortality, length of stay and medical expenditure in hospitalized elderly patients. J Infect Chemother. 2020;26:715-721.
65. Yokokawa H, Yuasa M, Nedsuwan S, Moolphate S, Fukuda H, Kitajima T, Kazuo Minematsu K, Tanimura S, Marui E. An impact of dietary intervention on blood pressures among diabetic and/or hypertensive patients with high risk of cardiovascular disorders in Northern Thailand by Cluster randomized trial. J Gen Fam Med. 2021;22: 28-37.
66. Naito T, Endo K, Fukushima S, Suzuki M, Fukui Y, Saita M, Yokokawa H. A preliminary analysis of the performance of a targeted HIV electronic medical records alert system: A single hospital experience. J Infect Chemother. 2021;27:123-125.
67. Goto K, Yokokawa H, Fukuda H, Saita M, Hamada C, Hisaoka T, Naito T. An association between subcutaneous fat mass accumulation and Hypertension. J Gen Fam Med. 2021;00:1-9.
68. Yokokawa H, Fukuda H, Saita M, Goto K, Kaku T, Miyagami T, Takahashi Y, Hamada C, Hisaoka T, Naito T. An association between visceral or subcutaneous fat accumulation and diabetes mellitus among Japanese subjects. Diabetol Metab Syndr. 2021;13:44.
69. Hayashi Y, Yokokawa H, Fukuda H, Saita M, Miyagami T, Takahashi Y, Hisaoka T, Naito T. Association between visceral or subcutaneous fat accumulation and B-type natriuretic peptide among Japanese subjects: a cross-sectional study. J Clin Med. 2021;10:1315.
70. Hamaya R, Fukuda H, Takebayashi M, Mori M, Matsushima R, Nakano K, Miyake K, Tani Y, Yokokawa H. The effects of kencom, an mHealth app with integrated functions for healthy lifestyles. J Med Internet Res. 2021;23: 1-13.
71. Okamoto A, Yokokawa H, Nagamine T, Fukuda H, Hisaoka T, Naito T. Efficacy and safety of semaglutide in glycemic control, body weight management, lipid profiles and other biomarkers among obese type 2 diabetes patients initiated or switched to semaglutide from other GLP-1 receptor agonists. J Diabetes Metab Disord. 2021; Published online 25. 10.1007/s40200-021-00899-9.
72. Fujisawa T, Fukuda H, Sakamoto N, Hojo M, Tomishima K, Ishii S, Yokokawa H, Saita M, Naito T, Nagahara A, Watanabe S, Isayama H. Relief Effect of Carbon Dioxide Insufflation in Transnasal Endoscopy for Health Checks-A Prospective, Double-Blind, Case-Control Trial. J Clin Med. 2022;11:1231. doi: 10.3390/jcm11051231.
73. Sachkouskaya A, Sharshakova T, Kovalevsky D, Rusalenko M, Savasteeva I, Goto A, Yokokawa H, Kumagai A, Takahashi J. Barriers to Prevention and Treatment of Type 2 Diabetes Mellitus Among Outpatients in Belarus. Front Clin Diabetes Healthc. 06 January 2022.

２．和文原著
1. 羽二生知美, 福田洋, 横川博英, 藤林和俊, 久岡英彦, 礒沼弘；高尿酸血症を含めた慢性腎臓病Chronic Kidney Disease（CKD）の危険因子の横断的検討．日本臨床生理学会雑誌 42, 249-255, 2012.
2. 横川博英，安村誠司，丹野高三，大澤正樹，小野田敏行，板井一好，川村和子，坂田清美．閉じこもりと要介護発生との関連についての検討；岩手県北地域コホート研究より．日本老年医学会雑誌 46, 447-457, 2009.
3. 鈴木直子，後藤あや, 横川博英, 安村誠司．地域在住高齢者のIADLの「実行状況」と「能力」の１年後の変化．日本老年医学会雑誌 46, 47-54, 2009.
4. 鈴木直子, 牧上久仁子, 後藤あや, 横川博英, 安村誠司．地域在住高齢者のIADLの「実行状況」と「能力」による評価の検討　基本チェックリストと老研式活動能力指標から．日本老年医学会雑誌，44，619-626，2007．
5. 舟見敬成，照井和史，横川博英．教育入院の長期効果と患者教育への一提案－行動変化ステージ別介入方法について－．東北理学療法学，18，13-17，2006．

研究者

教育活動

【学校法人順天堂】研究者情報データベース

研究業績詳細

横川 博英（ヨコカワ ヒロヒデ）

横川博英（ヨコカワヒロヒデ）